2576 Stock Overview

Zhejiang Taimei Medical Technology Co., Ltd. More details

2576 fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	1/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Revenue is forecast to grow 13.63% per year

Earnings have grown 5.5% per year over the past 5 years

Risk Analysis

No risks detected for 2576 from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Zhejiang Taimei Medical Technology Co., Ltd. Competitors

Viva Biotech Holdings

SEHK:1873

HK$1.7b

Frontage Holdings

SEHK:1521

HK$3.1b

Austar Lifesciences

SEHK:6118

HK$276.8m

Genscript Biotech

SEHK:1548

HK$20.2b

Price History & Performance

Summary of share price highs, lows and changes for Zhejiang Taimei Medical Technology
Historical stock prices
Current Share Price	HK$3.70
52 Week High	HK$11.68
52 Week Low	HK$3.10
Beta	0
1 Month Change	-26.29%
3 Month Change	-44.36%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-59.78%

Recent updates

Shareholder Returns

	2576	HK Life Sciences	HK Market
7D	5.7%	0.2%	2.1%
1Y	n/a	-31.6%	23.7%

Return vs Industry: Insufficient data to determine how 2576 performed against the Hong Kong Life Sciences industry.

Return vs Market: Insufficient data to determine how 2576 performed against the Hong Kong Market.

Price Volatility

Is 2576's price volatile compared to industry and market?
2576 volatility
2576 Average Weekly Movement	7.3%
Life Sciences Industry Average Movement	7.3%
Market Average Movement	6.5%
10% most volatile stocks in HK Market	14.0%
10% least volatile stocks in HK Market	3.0%

Stable Share Price: 2576 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: Insufficient data to determine 2576's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2013	783	Zhao Lu	www.taimeitech.com

Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders.

Zhejiang Taimei Medical Technology Co., Ltd. Fundamentals Summary

How do Zhejiang Taimei Medical Technology's earnings and revenue compare to its market cap?
2576 fundamental statistics
Market cap	HK$2.09b
Earnings (TTM)	-HK$381.57m
Revenue (TTM)	HK$612.14m

3.4x

P/S Ratio

-5.5x

P/E Ratio

Is 2576 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2576 income statement (TTM)
Revenue	CN¥575.96m
Cost of Revenue	CN¥385.93m
Gross Profit	CN¥190.03m
Other Expenses	CN¥549.04m
Earnings	-CN¥359.01m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.64
Gross Margin	32.99%
Net Profit Margin	-62.33%
Debt/Equity Ratio	0%

How did 2576 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/19 00:22
End of Day Share Price	2025/01/17 00:00
Earnings	2024/03/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhejiang Taimei Medical Technology Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yang Liu	Morgan Stanley

Zhejiang Taimei Medical Technology SEHK:2576 Stock Report